Arcturus Therapeutics Holdings Inc. Quarterly Debt-to-equity in % from Q1 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Arcturus Therapeutics Holdings Inc. quarterly Debt-to-equity history and growth rate from Q1 2020 to Q3 2024.
  • Arcturus Therapeutics Holdings Inc. Debt-to-equity for the quarter ending September 30, 2024 was 51.2 %, a 7.44% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 51.2 -4.12 -7.44% Sep 30, 2024
Q2 2024 56.7 -2.96 -4.96% Jun 30, 2024
Q1 2024 56.8 -12.7 -18.2% Mar 31, 2024
Q4 2023 52.5 -32 -37.9% Dec 31, 2023
Q3 2023 55.4 -31.9 -36.5% Sep 30, 2023
Q2 2023 59.7 -19 -24.2% Jun 30, 2023
Q1 2023 69.4 +3.93 +6% Mar 31, 2023
Q4 2022 84.5 +31 +58.1% Dec 31, 2022
Q3 2022 87.2 +47.1 +117% Sep 30, 2022
Q2 2022 78.7 +47.4 +151% Jun 30, 2022
Q1 2022 65.5 +36 +122% Mar 31, 2022
Q4 2021 53.4 +20.6 +62.7% Dec 31, 2021
Q3 2021 40.1 -17.4 -30.2% Sep 30, 2021
Q2 2021 31.4 -96.1 -75.4% Jun 30, 2021
Q1 2021 29.5 -182 -86% Mar 31, 2021
Q4 2020 32.8 Dec 31, 2020
Q3 2020 57.5 Sep 30, 2020
Q2 2020 127 Jun 30, 2020
Q1 2020 212 Mar 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.